CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response (Q47932543)

6 February 2018

title

CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response (English)

1 reference

6 February 2018

1 reference

1 reference

4

1 reference

6 February 2018

author name string

Roland Seiler

1

1 reference

6 February 2018

George N Thalmann

2

1 reference

6 February 2018

Diana Rotzer

3

1 reference

6 February 2018

Achim Fleischmann

5

1 reference

6 February 2018

publication date

26 July 2013

1 reference

6 February 2018

published in

Modern Pathology

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

87-95

1 reference

6 February 2018

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cycling to cancer with cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin D1 and prognosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Transcriptional regulation of the cyclin D1 gene at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Nuclear cyclin D1: an oncogenic driver in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Targeted therapies in bladder cancer--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.125

7 January 2021

10.1038/MODPATHOL.2013.125

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018